Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04702958 · ClinicalTrials.gov registry record
TRANSFORM-HF Ancillary Mechanistic Study
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 150
- Enrollment target
NCT04702958 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 150 participants.
The verdict
NCT04702958 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Patients with heart failure are frequently treated with diuretics, including furosemide and torsemide, but it is not known if one is better than the other. The TRANSFORM-HF trial is studying if torsemide is superior than furosemide for reducing the endpoint of death or hospitalization, but is not designed to study why. This ancillary study seeks to measure proteins in the blood and urine to help explain the underlying mechanism for why patients who take one of these diuretics may have better outcomes than patients who take the other.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2023-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04702958
The ClinicalTrials.gov registry entry for NCT04702958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04702958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04702958 about?
NCT04702958 is a clinical study titled "TRANSFORM-HF Ancillary Mechanistic Study". Patients with heart failure are frequently treated with diuretics, including furosemide and torsemide, but it is not known if one is better than the other. The TRANSFORM-HF trial is studying if torsemide is superior than furosemide for reducing the endpoint of death or hospitalization, but is not de...
What is the current status of trial NCT04702958?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2020-12-10. Estimated completion is 2023-05-30.
Who is sponsoring clinical trial NCT04702958?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.